Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of the Thrombospondin-1–Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Cancer Clinicians often assume that children with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback